Evidence map›Paper›PMID 28259837›Full record

ArticleActa biomaterialia2017

Shape memory polymers with enhanced visibility for magnetic resonance- and X-ray imaging modalities.

A C Weems, J M Szafron, A D Easley, S Herting, J Smolen, D J Maitland

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

A C WeemsDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA.
J M SzafronDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA.
A D EasleyDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA.
S HertingDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA.
J SmolenDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA.
D J MaitlandDepartment of Biomedical Engineering, 5045 Emerging Technologies Building, 3120 TAMU Texas A&M University, College Station, TX 77843-3120, USA. Electronic address: djmaitland@tamu.edu.
Texas A&M University · US

Funding

Shape Memory Polymer Embolic Foams for Treating Cerebrovascular AneurysmsU01NS089692 · NINDS · TEXAS ENGINEERING EXPERIMENT STATION · PI MAITLAND, DUNCAN J · 2015 to 2018
$2.5M
NINDS NIH HHS U01 NS089692
6 · The paper itself

Abstract

Currently, monitoring of minimally invasive medical devices is performed using fluoroscopy. The risks associated with fluoroscopy, including increased risk of cancer, make this method especially unsuitable for pediatric device delivery and follow-up procedures. A more suitable method is magnetic resonance (MR) imaging, which makes use of harmless magnetic fields rather than ionizing radiation when imaging the patient; this method is safer for both the patient and the performing technicians. Unfortunately, there is a lack of research available on bulk polymeric materials to enhance MR-visibility for use in medical devices. Here we show the incorporation of both physical and chemical modifying agents for the enhancement of both MR and X-ray visibility. Through the incorporation of these additives, we are able to control shape recovery of the polymer without sacrificing the thermal transition temperatures or the mechanical properties. For long-term implantation, these MR-visible materials do not have altered degradation profiles, and the release of additives is well below significant thresholds for daily dosages of MR-visible compounds. We anticipate our materials to be a starting point for safer, MR-visible medical devices incorporating polymeric components. STATEMENT OF SIGNIFICANCE: Shape memory polymers (SMPs) are polymeric materials with unique shape recovery abilities that are being considered for use in biomedical and medical device applications. This paper presents a methodology for the development of MR and X-ray visible SMPs using either a chemically loaded or physical loaded method during polymer synthesis. Such knowledge is imperative for the development and clinical application of SMPs for biomedical devices, specifically for minimally-invasive vascular occlusion treatments, and while there are studies pertaining to the visibility of polymeric particles, little work has been performed on the utility of biomaterials intended for medical devices and the impact of how adding multiple functionalities, such as imaging, may impact material safety and degradation.

Indexed as

Biodegradable PlasticsContrast MediaMagnetic Resonance ImagingMaterials TestingTomography, X-Ray3T3 CellsAnimalsMiceBiodegradable PlasticsContrast MediaCytocompatibilityMagnetic resonance imagingShape memory polymerX-ray imaging

Identifiers

PMID28259837
PMCPMC5811198
OpenAlexW2594690751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.